Corticosteroids
11
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Corticosteroids Prevent the Atrial Fibrillation After Cardiac Surgery
JAK Inhibitors' Efficacy in Bullous Pemphigoid
Topical Sulfasalazine and Oral Lichen Planus
Mapping Emotional Dynamics During Corticosteroid Treatment
Intra Articular Injection of Ozone With Corticosteroids vs PRGF in Knee Osteoarthritis
Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up
DEXAMETHASONE for Non-urgent Thoracic Surgery
Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
Short Term Corticosteroids in SARS-CoV2 Patients
Prognosis of SRD Patients in the ICU